Tuttle Capital Management’s Eli Lilly LLY Stock Holding History

Tuttle Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	900 +184	+26%	+$188K	0.73%	30
2026 Q1	$659K	Hold	716	–	–	1.08%	37
2025 Q4	$769K	Buy	+716	New	+$685K	1.7%	16
2020 Q4	–	Sell	-4,870	Closed	-$721K	–	234
2020 Q3	$721K	Buy	+4,870	New	+$754K	0.5%	42
2019 Q2	–	Sell	-44,079	Closed	-$5.72M	–	142
2019 Q1	$5.72M	Buy	44,079 +31,983	+264%	+$3.89M	1.15%	17
2018 Q4	$2.23M	Sell	12,096 -2,004	-14%	-$224K	0.85%	37
2018 Q3	$1.51M	Buy	+14,100	New	+$1.41M	0.29%	90

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tuttle Capital Management's LLY Position: Q2 2026 in Review

Tuttle Capital Management increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $188K and bringing the position to 900 shares worth $1.08M. The position accounts for 0.73% of the portfolio, ranked #30.

Tuttle Capital Management first reported a position in LLY in Q3 2018 and has held it in 7 quarters since. The position peaked at $5.72M in Q1 2019. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Tuttle Capital Management held 900 shares of Eli Lilly worth $1.08M as of Q2 2026.
Tuttle Capital Management bought 184 Eli Lilly shares in Q2 2026, an estimated $188K.
Eli Lilly made up 0.73% of Tuttle Capital Management's portfolio in Q2 2026, its #30 holding.
Tuttle Capital Management first reported a position in Eli Lilly in Q3 2018 and has held it in 7 quarters since.
Tuttle Capital Management's Eli Lilly position peaked at $5.72M in Q1 2019.
4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tuttle Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.